Esperion Therapeutics, Inc. · Brief

Next report

5 days

Nov 5 · before openest.Q3 FY26

Expected move

No implied move.

8 reportsHistory

0 of 8≥ implied

Nov 7 '24±14.3%▼−4.52%×0.32

Jan 16 '25±10.7%▲+2.26%×0.21

Mar 4 '25±21.9%▲+12.03%×0.55

May 6 '25±25.3%▼−7.10%×0.28

Aug 5 '25±19.8%▲+8.72%×0.44

Q3 FY25±21.8%▼−14.97%×0.69

Q4 FY25±9.3%▼−8.51%×0.91

Q1 FY26±15.3%▼−11.18%×0.73

quarterimplied−30%0+30%realized×

Q1 FY26±15.3%▼−11.18%×0.73

Q4 FY25±9.3%▼−8.51%×0.91

Q3 FY25±21.8%▼−14.97%×0.69

Aug '25±19.8%▲+8.72%×0.44

May '25±25.3%▼−7.10%×0.28

Mar '25±21.9%▲+12.03%×0.55

2 older reports

Jan '25±10.7%▲+2.26%×0.21

Nov '24±14.3%▼−4.52%×0.32

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 5 report · est.

Bull2

190managers reporting a position in the latest quarterly filings13F · Jun 30 '26

+30.50%change in shares held by largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2

30managers holding most of the reported value13F · Jun 30 '26

4 of 13largest reporting managers who cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Oct 28 '26once per report · top 2 per case

ESPR report session

No linked exposure.

No changes.

privateThesis 0 · Decisions 0 · Observations 0

No thesis.